FOS S.P.A. FOS S.p.A, (FOS:IM), a Genoese SME in the technology consulting and research sector, listed on the Euronext Growth Milan segment of the Italian Stock Exchange, active in the design and development of digital services and products for large industrial groups and the public administration, announces that it has obtained from the Italian Patent and Trademark Office in co-ownership with ENEA (National Agency for New Technologies, Energy and Sustainable Economic Development), the patent certificate for the industrial invention for the photometric station for in vitro diagnostic analysis using organic-based opto-electronic devices and photonic crystals.
The patent is owned by ENEA (70%) and FOS S.p.A. (30%). The patent, owned by ENEA (70%) and FOS S.p.A. (30%), was conceived and developed at the ENEA Nanomaterials and Devices Laboratory in Portici in collaboration with the CNR Institute of Applied Sciences and Intelligent Systems in Pozzuoli.
"The Photometric Station that we have developed makes it possible to perform enzyme immunoassays to detect the possible presence of antibodies or antigens in a sample, typically in blood, and to ascertain, for example, the presence of an infection, as in the case of the ELISA test - Enzyme Linked Immunosorbent Assay," explains Giuseppe Nenna, inventor of the patent along with other colleagues. ENEA.
This innovative system owes its uniqueness to the use of new-generation OLED optical sources that provide a wide spectral bandwidth to cover all
wavelengths usually used for this type of diagnostic test, as well as a "rationalisation" of examinations (e.g. one device to illuminate several samples to be examined). Added to this is the use of photonic crystals, which are nano-structures made with regular distances in order to select appropriate wavelengths.
"Our system also features an innovative light filtering method based on photonic crystals, which we developed in collaboration with the CNR and which allows precise and adaptable selection of the wavelengths and bandwidths used and most required for sample analysis," adds Giuseppe Nenna, who developed the filtering method together with the CNR's 'Nanophotonics and Artificial Materials' research group led by Lucia Petti and, in particular, with the contribution of Massimo Rippa and Ambra Vestri.
The use of organic devices keeps the cost of the system down and its level of integration can be increased more easily, allowing for smaller footprints and lighter weights and making the system compact, easily integrated and scalable even on flexible substrates, avoiding the need for additional optical fibres and interference filters.
"This patent further extends the virtuous collaboration between research and business that ENEA and FOS have been putting into practice for about 10 years" - explains Giorgio Allasia, Director of Engineering and R&D Business Unit - Head of Technology Transfer of FOS S.p.A.- "After the positive experiences in the Agro field, the technology of the Photometric Station that has been patented represents a strong point of innovation in in vitro analysis oriented to the detection of infections by pathogens. With thenext steps towards consolidation and engineering of the Photometric Station, it will be possible to have a new medical apparatus and new processes that will be useful in the prevention of pandemics".
****
FOS S.p.A. FOS S.p.A., founded in Genoa in 1999 - led by Brunello Botte, born in 1945, Chairman of FOS S.p.A., Matteo Pedrelli, born in 1967, Vice Chairman and Managing Director of FOS S.p.A., co-founder of FOS S.p.A. together with Enrico Botte, born in 1976, also Managing Director of FOS S.p.A. - is the head of a Group that offers digital services and innovation projects through four business lines: "Information Technology," "Communication Technology," "Engineering & Technology Transfer" and "Automation & Solution". is at the head of a Group that offers digital services and innovation projects, through four business lines: "Information Technology", "Communication Technology", "Engineering & Technology Transfer" and "Automation & Solution", for major groups in industry, biomedical, healthcare, transport, finance, telco and public administration. The acquisition in December 2020 of InRebus Technologies adds a new business line dedicated to Digital Learning. The Group employs 214 people distributed in 8 locations - Genoa, Milan, Turin, Rome, Caserta, Benevento, Bolzano and Vilnius (Lithuania) - and 6 research laboratories (two in Genoa, one in Naples, Bolzano, Enna and Kaunas in Lithuania) in collaboration with university centres (University of Genoa, University of Bolzano, University of Enna, Technical University of Kaunas in Lithuania) and public bodies such as ENEA (National Agency for New Technologies, Energy and Sustainable Economic Development). FOS S.p.A. is listed on the Euronext Growth Milan market organised and managed by Borsa Italiana S.p.A. In 2020 the Group recorded the following pro-forma results: Value of Production of Euro 15.8 million, EBITDA of Euro 2.9 million and Net Profit of Euro 1.0 million.
****
CONTACTS
r.stasio@barabino.it
+39 366 6202521
sabina.petrella@fos.it
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
FOS S.p.A. published this content on 03 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 December 2021 15:31:07 UTC.
